VELL BIOLOGICS INDIA PRIVATE LIMITED
Bengaluru, Karnataka
In their own words
Vell Biologics India Private Limited serves as a premier access platform engineered to deliver timely, affordable, and life-saving biologics for rare and chronic diseases. Our mission is to expedite the clinical uptake of global medical innovations by bridging critical gaps in the current healthcare infrastructure. We achieve this through strategic alliances with world-class manufacturers and the sophisticated navigation of complex multi-jurisdictional regulatory paths. By integrating scientific excellence with operational rigor, Vell Biologics India Private Limited is positioned to lead the rare disease care sector across India and emerging markets. We are committed to establishing a sustainable ecosystem that prioritizes patient-first outcomes, ensuring that advanced therapies are not only available but successfully reach the vulnerable populations who require them most.
Written by the company on its public Startup India profile. Not verified by us.
What the record says
- DPIIT recognition number
- DIPP251035
- CIN
- U46497KA2024PTC194487
- Registered on Startup India
- 2026
- Self-declared stage
- Prototype
Where this is
District
Bengaluru
Karnataka
Startup India records the district. We do not have a street address for this company, and we will not invent one.
No point is drawn, because we do not have one.
Geocode confidence: medium
What we do not know
- no incorporation date
- no funding signal of any kind
- no address beyond the district
We have no liveness signal for any company on this site: no filings feed, no revenue, no check that the website still resolves. A record existing here means a record exists, not that a business is trading.
Is this your company?
Everything here comes from public government records. If something is wrong, the authoritative place to correct it is the Startup India portal itself, and we will pick the correction up on the next monthly snapshot. To flag an error on our side, write to trust@indianstartupmap.com.